As previously disclosed, Bio-Rad's accounting firm needs more time to complete its audit and the company plans to file the form as soon as possible.
WUSTL bioinformatics spinout PierianDx disclosed in an SEC filing that it has raised slightly more than $3 million of a $5 million offering.
The New York Stock Exchange gave Alere an additional six months to file its 2016 annual report, but it also said it could commence delisting proceedings at any time.
The company borrowed $205 million in revolving loans from the credit facility, which matures on December 23, 2021.
The gene editing company has notified the SEC it plans to trade on the Nasdaq beginning in 2016 under the ticker “EDIT.”
The firm is selling stock and warrants to purchase stock to raise money for general corporate purposes and working capital.
Helicos said it will require "significant additional capital" before the end of the year to fund its operations. The company's "current financial resources raise substantial doubt about its ability to continue as a going concern."
US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.
A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.
The New York Times writes about the appearance of mosaicism in healthy people.
In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.